118 related articles for article (PubMed ID: 9595475)
21. Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats.
Gardiner SM; March JE; Kemp PA; Mullins JJ; Bennett T
Br J Pharmacol; 1995 Oct; 116(4):2237-44. PubMed ID: 8564254
[TBL] [Abstract][Full Text] [Related]
22. Trigeminal nerve ganglion stimulation-induced neurovascular reflexes in the anaesthetized cat: role of endothelin(B) receptors in carotid vasodilatation.
Raval P; Bingham S; Aiyar N; Elliott JD; Hunter AJ; Ohlstein EH; Parsons AA
Br J Pharmacol; 1999 Jan; 126(2):485-93. PubMed ID: 10077242
[TBL] [Abstract][Full Text] [Related]
23. Effect of endothelin antagonists on the renal haemodynamic and tubular responses to ischaemia-reperfusion injury in anaesthetised rats.
Ajis A; Bagnall NM; Collis MG; Johns EJ
Exp Physiol; 2003 Jul; 88(4):483-90. PubMed ID: 12861335
[TBL] [Abstract][Full Text] [Related]
24. Evidence for the existence of endothelin-B receptor subtypes and their physiological roles in the rat.
Gellai M; Fletcher T; Pullen M; Nambi P
Am J Physiol; 1996 Jul; 271(1 Pt 2):R254-61. PubMed ID: 8760228
[TBL] [Abstract][Full Text] [Related]
25. Renal and hemodynamic effects of endothelin in anesthetized dogs.
Tsuchiya K; Naruse M; Sanaka T; Naruse K; Zeng ZP; Nitta K; Demura H; Shizume K; Sugino N
Am J Hypertens; 1990 Oct; 3(10):792-5. PubMed ID: 2222945
[TBL] [Abstract][Full Text] [Related]
26. Temporal differences between the involvement of angiotensin II and endothelin in the cardiovascular responses to endotoxaemia in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1996 Dec; 119(8):1619-27. PubMed ID: 8982510
[TBL] [Abstract][Full Text] [Related]
27. Functional role of ETB receptors in the renal medulla.
Vassileva I; Mountain C; Pollock DM
Hypertension; 2003 Jun; 41(6):1359-63. PubMed ID: 12719443
[TBL] [Abstract][Full Text] [Related]
28. Renal protection by a dual ETA/ETB endothelin antagonist, L-754,142, after aortic cross-clamping in the dog.
Krause SM; Walsh TF; Greenlee WJ; Ranaei R; Williams DL; Kivlighn SD
J Am Soc Nephrol; 1997 Jul; 8(7):1061-71. PubMed ID: 9219155
[TBL] [Abstract][Full Text] [Related]
29. Influence of aminoguanidine and the endothelin antagonist, SB 209670, on the regional haemodynamic effects of endotoxaemia in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1996 Aug; 118(7):1822-8. PubMed ID: 8842449
[TBL] [Abstract][Full Text] [Related]
30. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.
Warner TD; Allcock GH; Vane JR
Br J Pharmacol; 1994 May; 112(1):207-13. PubMed ID: 8032643
[TBL] [Abstract][Full Text] [Related]
31. Renal actions of endothelin: interaction with prostacyclin.
Chou SY; Dahhan A; Porush JG
Am J Physiol; 1990 Oct; 259(4 Pt 2):F645-52. PubMed ID: 2221102
[TBL] [Abstract][Full Text] [Related]
32. Contribution of endogenous endothelin-1 to the maintenance of vascular tone: role of nitric oxide.
Gellai M; De Wolf R; Fletcher T; Nambi P
Pharmacology; 1997 Dec; 55(6):299-308. PubMed ID: 9413859
[TBL] [Abstract][Full Text] [Related]
33. Renal effects of endothelin in anesthetized rabbits.
Ono N; Matsui T; Yoshida M; Suzuki-Kusaba M; Hisa H; Satoh S
Eur J Pharmacol; 1998 Oct; 359(2-3):177-84. PubMed ID: 9832389
[TBL] [Abstract][Full Text] [Related]
34. Renal and femoral vascular responses to endothelin-1 in dogs: role of prostaglandins.
Miura K; Yukimura T; Yamashita Y; Shimmen T; Okumura M; Yamanaka S; Imanishi M; Yamamoto K
J Pharmacol Exp Ther; 1991 Jan; 256(1):11-7. PubMed ID: 1988651
[TBL] [Abstract][Full Text] [Related]
35. Effects of ET(A) - and ET(B)-receptor antagonists on regional kidney blood flow, and responses to intravenous endothelin-1, in anaesthetized rabbits.
Evans RG; Madden AC; Oliver JJ; Lewis TV
J Hypertens; 2001 Oct; 19(10):1789-99. PubMed ID: 11593099
[TBL] [Abstract][Full Text] [Related]
36. Prevention of cyclosporine A-induced renal vasoconstriction by the endothelin receptor antagonist SB 209670.
Brooks DP; Contino LC
Eur J Pharmacol; 1995 Dec; 294(2-3):571-6. PubMed ID: 8750720
[TBL] [Abstract][Full Text] [Related]
37. Effects of an ET1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6-21) in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T; Davenport AP; Edvinsson L
Br J Pharmacol; 1994 Jun; 112(2):477-86. PubMed ID: 8075866
[TBL] [Abstract][Full Text] [Related]
38. Plasma- and cerebrospinal fluid-immunoreactive endothelin-1: effects of nonpeptide endothelin receptor antagonists with diverse affinity profiles for endothelin-A and endothelin-B receptors.
Willette RN; Sauermelch CF; Storer BL; Guiney S; Luengo JI; Xiang JN; Elliott JD; Ohlstein EH
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S149-57. PubMed ID: 9595425
[TBL] [Abstract][Full Text] [Related]
39. Effects of dexamethasone and SB 209670 on the regional haemodynamic responses to lipopolysaccharide in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1996 May; 118(1):141-9. PubMed ID: 8733587
[TBL] [Abstract][Full Text] [Related]
40. Role of endothelin receptor subtypes in the in vivo regulation of renal function.
Clavell AL; Stingo AJ; Margulies KB; Brandt RR; Burnett JC
Am J Physiol; 1995 Mar; 268(3 Pt 2):F455-60. PubMed ID: 7900845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
